MedTrace Logo

Advisory Board on Cancer, Infertility and Pregnancy

NCT04904263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-05-27

No results posted yet for this study

Summary

The Advisory Board on Cancer, Infertility and Pregnancy provides a platform where physicians from all over the world can request recommendations regarding the medical care of pregnant women diagnosed with cancer or regarding fertility preservation. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards.

To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

Conditions

  • Cancer in Pregnancy
  • Fertility Preservation
  • Cancer
  • Pregnancy

Sponsors & Collaborators

  • Kom Op Tegen Kanker

    collaborator OTHER

  • European Research Council

    collaborator OTHER

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Frederic Amant, MD,PhD · Universitaire Ziekenhuizen KU Leuven

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-22
Primary Completion
2024-05-22
Completion
2024-05-22

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904263 on ClinicalTrials.gov